This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Glaxo Wellcome Inc., Smithkline Beecham (Cork) Ltd. Active years: 1999-2014.
Company Filing History:
Years Active: 1999-2014
Title: Barry Howard Carter: Innovator in Pharmaceutical Formulations
Introduction
Barry Howard Carter is a notable inventor based in Kinston, NC (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work primarily focuses on innovative oral pharmaceutical formulations that address various medical disorders.
Latest Patents
One of his latest patents involves a pharmaceutical composition that describes oral pharmaceutical formulations containing ditosylate salts of 4-quinazolineamines. This invention is particularly relevant for treating disorders characterized by aberrant erbB family PTK activity. His research and development in this area highlight his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Barry has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and SmithKline Beecham Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug formulations.
Collaborations
Barry has collaborated with several professionals in his field, including Jane Muse Partin and Peter Gregory Varlashkin. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Barry Howard Carter's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through effective treatments. His patents and collaborations reflect a career marked by significant achievements in the field.